David Lamadrid - Chief Financial Officer, Cytosorbents Corp

As of September 9, 2011


David Lamadrid Net Worth

  • Net worth is estimated to be at least $180.05K
  • Owns at least 7,837,500 units of Cytosorbents Corp stock
  • Sold an estimated value of $2.69K in the last year at Cytosorbents Corp

David Lamadrid Trading

  • Largest sale of shares was 12,500 units , worth over $2.69K on September 9, 2011
  • In total has made about 2 transactions over a year
  • Usually trades in May and September, with the busiest year in 2011 and 2010
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

David Lamadrid Mailing Address

  • Mailing address is Medasorb Technologies 7 Deer Park Drive, Suite K Monmouth Junction NJ 08852 NJ

Cytosorbents Corp Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Phillip P. Chan, MD, PhD 2020 $455,520 $260,557 $361,800 $298,313 $12,000 $1,388,190
Phillip P. Chan, MD, PhD 2019 $438,000 $99,645 $484,075 $370,656 $12,000 $1,404,376
Phillip P. Chan, MD, PhD 2018 $400,000 $160,000 $337,550 $337,745 $12,000 $1,247,295
Vincent J. Capponi, MS 2020 $400,000 $197,208 $326,223 $253,566 - $1,176,997
Vincent J. Capponi, MS 2019 $363,540 $57,258 $433,744 $315,058 - $1,169,600
Vincent J. Capponi, MS 2018 $332,000 $132,800 $298,300 $316,520 - $1,079,620
Kathleen P. Bloch, MBA, CPA 2020 $349,460 $138,386 $259,290 $223,735 - $970,871
Kathleen P. Bloch, MBA, CPA 2019 $323,025 $50,876 $347,954 $277,992 - $999,847
Kathleen P. Bloch, MBA, CPA 2018 $295,000 $118,000 $272,395 $268,188 - $953,583
Efthymios N. Deliargyris, MD 2020 $253,212 $101,640 $131,800 $331,912 $8,654 $827,217
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1175151/000110465921051985/tm2113212-1_def14a.htm

Cytosorbents Corp Insider Trading

  • The most recent transaction was 15,000 units bought on January 3, 2022 by Phillip P Chan worth over $60.75K
  • In the last 10 years, insiders at Cytosorbents Corp sold an estimated value of $6.87M and bought an estimated value of $5.11M
  • The most active traders are Al Kraus, Director,  Kathleen P Bloch, Chief Financial Officer,  and Vincent Capponi, President
  • Insider trading is most common in July, with the busiest year in 2014

Cytosorbents Corp Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1